RAP 3.13% 15.5¢ resapp health limited

Terrible Branding

  1. 549 Posts.
    lightbulb Created with Sketch. 76
    The article by UQ has Dr Abeyratne quoting two names for the product, one of which is Coughalytics, the other which is Pneumophone.

    I like the company, tech and use case. But branding matters. The names are terrible. I hope these aren’t what they are going to market with. Look at the strength of the name of Xero or Quickbooks (communicate a financial number ‘zero’ or a result ‘quick books’) versus MYOB (no stranger would know what that means). Afterpay versus Zippay is another
    great example - one communicates what it is intrinsically, the other doesn’t.

    It’s certainly not the only reason for the success or failure of any of those companies but for a new product, looking to get adopted, this stuff matters
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
(20min delay)
Last
15.5¢
Change
-0.005(3.13%)
Mkt cap ! $107.9M
Open High Low Value Volume
16.0¢ 16.0¢ 15.5¢ $68.39K 434.3K

Buyers (Bids)

No. Vol. Price($)
9 371252 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 387912 10
View Market Depth
Last update - 16.10pm 18/07/2019 (20 minute delay) ?
(live)
Last
15.5¢
  Change
-0.005 ( 3.13 %)
Open High Low Volume
16.0¢ 16.0¢ 15.5¢ 340721
Last updated 15.55pm 18/07/2019 (live) ?
RAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.